DNA Plc's Financial Statements Bulletin 2016: DNA's

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
147
DNA Plc's Financial Statements Bulletin 2016: DNA's profitability improved significantly in 2016

Summary

Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period).

October-December 2016

  • Net sales increased 5.2% and amounted to EUR 225.2 million (213.9 million).
  • EBITDA decreased 5.4% to EUR 51.3 million (54.2 million). The EBITDA percentage of net sales was 22.8% (25.3%).
  • Comparable EBITDA increased 6.1% and was EUR 57.5 million (54.2 million).
  • The operating result decreased 24.8% and was EUR 14.5 million (19.3 million). Operating result as a percentage of net sales decreased and was 6.4% (9.0%).
  • The comparable operating result increased 7.6% and was EUR 20.8 million (19.3 million).
  • Revenue per user (ARPU) for mobile communications amounted to EUR 17.5 (17.0).
  • The mobile communication subscription turnover rate (CHURN) was 17.8% (15.9%).

January-December 2016

  • Net sales increased 3.6% and amounted to EUR 858.9 million (828.8 million).
  • EBITDA increased 3.8% and was EUR 236.3 million (227.7 million). The EBITDA percentage of net sales was 27.5% (27.5%).
  • Comparable EBITDA increased 9.0% and was EUR 247.1 million (226.7 million).
  • Operating result increased 24.8% and was EUR 91.2 million (73.1 million). Operating result as a percentage of net sales increased and was 10.6% (8.8%).
  • The comparable operating result increased 41.7% to EUR 102.1 million (72.0 million).
  • The mobile communication subscription base grew 4.6%, totalling 2,742,000 (2,621,000).
  • Revenue per user (ARPU) for mobile communications amounted to EUR 17.1 (17.0).
  • The mobile communication subscription turnover rate (CHURN) was 16.1% (16.0%).
  • The fixed-network subscription base (voice, broadband and cable television) decreased slightly and was 1,113,000 subscriptions at the end of December (1,120,000).

DNA's outlook for 2017

DNA's net sales are expected to remain at a same level and the comparable operating result is expected to improve somewhat in 2017 compared to 2016. The Group's financial position and liquidity is expected to remain at a healthy level.

Key figures

Figures are unaudited.

EUR million 10-12/2016 10-12/2015 Change, % 1-12/2016 1-12/2015 Change, %
Net sales 225.2 213.9 5.2 % 858.9 828.8 3.6 %
EBITDA 51.3 54.2 -5.4 % 236.3 227.7 3.8 %
- % of net sales 22.8 % 25.3 %   27.5 % 27.5 %  
Comparable EBITDA * 57.5 54.2 6.1 % 247.1 226.7 9.0 %
- % of net sales 25.5 % 25.3 %   28.8 % 27.3 %  
Depreciation, amortisation and impairment 36.7 34.9   145.0 154.6  
Operating result, EBIT 14.5 19.3 -24.8 % 91.2 73.1 24.8 %
- % of net sales 6.4 % 9.0 %   10.6 % 8.8 %  
Comparable operating result* 20.8 19.3 7.6 % 102.1 72.0 41.7 %
- % of net sales 9.2 % 9.0 %   11.9 % 8.7 %  
Net result before tax 12.2 16.7 -27.2 % 81.7 61.6 32.6 %
Net result for the period 9.6 14.0 -31.1 % 65.2 50.0 30.3 %
Return on investment (ROI), % 6.1 8.2   9.6 7.6  
Return on equity (ROE), % 6.8 10.8   11.6 9.7  
Capital expenditure 58.7 70.9 -17.2 % 143.6 154.7 -7.2 %
Cash flow after investing activities 3.8 18.1   83.5 97.3  
Free cash flow to equity - -   92.6 101.5  
Net debt, EUR million - -   321.7 412.3 -22.0 %
Net debt/EBITDA 1.57 1.90   1.36 1.81  
Net gearing, % - -   53.9 78.5  
Equity ratio, % - -   48.4 44.1  
Basic earnings per share, EUR 0.07 0.11   0.51 0.39  
Diluted earnings per share, EUR 0.07 0.11   0.51 0.39  
Personnel at the end of period - -   1 668 1 672 -0.2 %

*Group key figures

CEO's review

2016 has been a strong year for DNA, in terms of financial development, customer base growth and customer satisfaction. Our net sales increased to EUR 858.9 million. Our profitability improved significantly as our operating result grew 24.8 percent and was EUR 91.2 million, or 10.6 percent of net sales, leading to earnings per share of EUR 0.51. Net sales were driven by the strong growth in service revenue (net sales less sales of goods and interconnection charges) as well as the positive development of mobile device sales. Our service revenue was boosted in particular by the increased sales of mobile subscriptions and growing use of mobile data as 4G subscriptions become more common. Our net sales were burdened by lower interconnection earnings as well as weaker demand for pay-TV services.

Favourable development of our mobile communication subscription base continued in 2016. It grew by 121,000 subscriptions, reaching 2.7 million in total. Our fixed-network subscription base decreased by 7,000 and totalled 1.1 million at the end of the year. This is due to the drop in the number of fixed-network voice subscriptions. The number of fixed-network broadband and cable television subscriptions increased by some 6,000 in total during 2016.

DNA shares were listed on the official list of Nasdaq Helsinki towards the end of 2016. Listing is an important milestone in developing DNA to an even stronger telecommunications company in the Finnish market. The final subscription price was EUR 10.10 per share and our IPO was oversubscribed. After the listing, we have more than 11,000 shareholders. Operating result in fourth quarter was affected by listing related costs, however, net sales and comparable operating profit improved clearly.

We made significant investments in our 4G network in 2016, which has been largely completed by the end of the year. The construction of DNA's and Sonera's shared mobile communication network got under way in the spring of 2015 and was also completed by the end of 2016. During these 18 months, more comprehensive, high-speed telecommunications connections have been made available for more than 760,000 residents in sparsely populated areas. We estimate that our operative capital expenditure will decrease as the focus of our mobile communication network investments shifts from network modernisation and coverage expansion to capacity expansion in the coming years.

In 2016, 4G mobile data traffic volumes in DNA's networks grew some 120 percent. According to a report released by research company Tefficient in December 2016, DNA's customers have the highest mobile data usage in the world per subscription. DNA carried as much as 9.9 gigabytes of data per subscription each month between January and September 2016.

The Finnish economy is slowly returning to growth which is expected to affect positively customer demand. We expect the service revenue to increase also in 2017. However, net sales are expected to remain at the same level than in 2016 because of lower interconnection earnings. Increasing service revenue and continuous improvement in operational efficiency are expected to increase comparable operating result somewhat in 2017 compared to 2016.

We will continue our measures to improve our customer experience further in 2017. We will also continue to focus on employee satisfaction and the employees' professional development with the aim of creating a team of top experts that has a dedicated and qualified person for every task.

Jukka Leinonen President and CEO

 

DNA's financial publications and events in 2017:

  • Interim Report January-March 2017, 21 April 2017
  • Half year Financial Report, 18 July 2017
  • Interim Report January-September, 20 October 2017
  • DNA Plc's Annual General Meeting, Wednesday 22 March 2017

Additional information: Jukka Leinonen, CEO, DNA Plc, tel. +358 44 044 1000, jukka.leinonen@dna.fi Timo Karppinen, CFO, DNA Plc, tel. +358 44 044 5007, timo.karppinen@dna.fi Marja Mäkinen, Head of IR, DNA Plc, tel. +358 44 044 1262, marja.makinen@dna.fi   DNA Corporate Communications, tel. +358 44 044 8000, viestinta@dna.fi

Distribution: Nasdaq Helsinki Key media www.dna.fi

DNA Plc is a Finnish telecommunications group providing high-quality voice, data and TV services for communication, entertainment and working. DNA is Finland's largest cable operator and the leading pay TV provider in both the cable and terrestrial networks. For DNA, the key area for growth in the Corporate Business is the new way of working, independent of time and place, facilitated by smart mobile devices, diverse communication services and rapid connections. In 2015, DNA recorded a turnover of EUR 859 million and an operating profit of EUR 91 million. DNA has more than 3.8 million mobile communications and fixed network customer subscriptions. The Group also includes DNA Store, Finland's largest retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki. For more information, please visit www.dna.fi, Twitter @DNA_fi, @DNA_Business and @DNA_Palvelu and Facebook.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...8615dd5ea4

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 97

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
VILVA's Global Reach: Power Testing's Next Phase

Updated Category News Views 23

A Power Play on Global Markets Taking a page from its relentless pursuit of quality and innovation, VILVA Electronics is bolstering its foothold on the international stage. Based in Shenzhen, this savvy player is reaching out for strategic partners like fishing for that perfect bite, hoping to reel in catches that understand the nitty-gritty of the local ponds—their...

Continue Reading
AI Faces Accountability Trials in Business 2027

Updated Category News Views 105

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Continue Reading
Global Vineyards List: New Entrants & Rankings Unveiled

Updated Category News Views 212

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Continue Reading
Net at Work Enhances Offering with K&R Acquisition

Updated Category News Views 24

Net at Work Makes a Strategic Move Out of the blue, Net at Work, a prominent figure in the North American tech scene, zeroes in on boosting their expertise with the acquisition of K&R Consulting Group. It's all about expanding their horizons, and snagging K&R doesn't just double down on their ERP game, it broadens their client base in manufacturing, distribution, and...

Continue Reading
Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 100

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
Zions Bank Spurs Idaho's Small Biz Boom in 2026

Updated Category News Views 85

Riding the Small Business Tsunami in Idaho You don't hear it every day, but Idaho's small business scene is hotter than a frypan—a nod to the entrepreneurial fire blazing in the state, and Zions Bank is holding the torch. In 2026, despite dealing with the uphill battles of inflation, tariffs, and labor scarcity, those entrepreneurs still managed to carve out a spot at...

Continue Reading
California Credit Union's Toy Drive Brings Holiday Cheer

Updated Category News Views 44

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 191

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 135

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading

Top 5 Most Recently Viewed Articles

Getinge's Early 2025 Financial Results: Insights and Strategies

Updated Category News Views 521

Sales Growth and Performance Overview Getinge has reported a strong performance for the first quarter of 2025, characterized by an organic sales growth of 6.2%. Despite facing currency headwinds, the medical technology company's positive trajectory continues to impress. The rise in order intake, marked at 2.9%, further cements Getinge's position as a key player in the...

Continue Reading
UnitedHealth's 2025 Outlook: Insights Amid Industry Challenges

Updated Category News Views 1417

UnitedHealth's Anticipated 2025 Outlook Investors eagerly await significant insights into UnitedHealth Group's (NYSE: UNH) projections for 2025 as the company prepares to release its quarterly results. This anticipation follows the recent tragic event involving executive Brian Thompson, whose murder led to the cancellation of crucial investor day presentations. With the...

Continue Reading
Industrial Nitrogen Market Poised for Significant Growth Ahead

Updated Category News Views 126

The Promising Future of the Industrial Nitrogen Market Recent analyses indicate a bright future for the global industrial nitrogen market, which is anticipated to reach a value of USD 38.29 billion in the next few years. This projection reflects a strong compound annual growth rate (CAGR) of 6.1% based on recent evaluations. The growth trend is largely driven by...

Continue Reading
Akeso Showcases Groundbreaking IL-1RAP Antibody Research

Updated Category News Views 206

Akeso Showcases Groundbreaking IL-1RAP Antibody Research Akeso, Inc. (HKEX: 9926.HK) has unveiled promising data from preclinical studies of a new monoclonal antibody known as AK135. This innovative treatment specifically targets the IL-1 receptor accessory protein (IL-1RAP) and effectively blocks multiple pro-inflammatory pathways. The recent findings were presented at a...

Continue Reading
Vor Bio's Pioneering Research in IgA Nephropathy Presentation

Updated Category News Views 164

Vor Bio Unveils Groundbreaking IgA Nephropathy Study at ASN 2025 CAMBRIDGE, Mass. -- Vor Bio, a leader in clinical-stage biotechnology focused on autoimmune diseases, is set to make a significant impact at the upcoming American Society of Nephrology’s Kidney Week 2025. They will present clinical data from a Phase 3 study conducted in collaboration with RemeGen Co., Ltd,...

Continue Reading